Cargando…

Therapeutic Strategies for SLE Involving Cytokines: Mechanism-Oriented Therapies Especially IFN-γ Targeting Gene Therapy

Systemic lupus erythematosus (SLE: lupus) is a chronic complicated autoimmune disease and pathogenesis is still unclear. However, key cytokines have been recognized. Interferon (IFN)-γ and also IFNα/β are of particular importance. Depending on the concept that lupus is a helper T(Th)1 disease and th...

Descripción completa

Detalles Bibliográficos
Autor principal:	Hayashi, Toshiharu
Formato:	Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2010
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2933908/ https://www.ncbi.nlm.nih.gov/pubmed/20827419 http://dx.doi.org/10.1155/2010/461641

Ejemplares similares

IFN-γ, should not be ignored in SLE
por: Liu, Wenping, et al.
Publicado: (2022)

Activity Disease in SLE Patients Affected IFN-γ in the IGRA Results
por: Maharani, Winni, et al.
Publicado: (2020)

IFN-λ1 with Th17 axis cytokines and IFN-α define different subsets in systemic lupus erythematosus (SLE)
por: Oke, Vilija, et al.
Publicado: (2017)

The STAT4 SLE risk allele rs7574865[T] is associated with increased IL-12-induced IFN-γ production in T cells from patients with SLE
por: Hagberg, Niklas, et al.
Publicado: (2018)

IFNα Inducible Models of Murine SLE
por: Liu, Zheng, et al.
Publicado: (2013)

Targeted therapeutics in SLE: emerging strategies to modulate the interferon pathway
por: Oon, Shereen, et al.
Publicado: (2016)

The Therapeutic Strategies for SLE by Targeting Anti-dsDNA Antibodies
por: Wang, Yaqi, et al.
Publicado: (2021)

The role of IFN-γ production during retroviral infections: an important cytokine involved in chronic inflammation and pathogenesis
por: Cordeiro, Patrícia Azevedo Soares, et al.
Publicado: (2022)

B Cell Tolerance and Targeted Therapies in SLE
por: Parodis, Ioannis, et al.
Publicado: (2023)

Cytokine and reactivity profiles in SLE patients following anti-CD19 CART therapy
por: Nunez, Daniel, et al.
Publicado: (2023)

Cytokine-Induced Monocyte Characteristics in SLE
por: Zhang, Zhe, et al.
Publicado: (2010)

The role of IFN-γ-signalling in response to immune checkpoint blockade therapy
por: Wong, Chun Wai, et al.
Publicado: (2023)

Production of IFN-α by Natural IFN-α Producing Cells (NIPC), induced by apoptotic cells and autoantibodies via FcγRII, could be a pivotal event in the etiopathogenesis of SLE
por: Rönnblom, LR, et al.
Publicado: (2002)

Association of IFN-γ : IL-10 Cytokine Ratio with Nonsegmental Vitiligo Pathogenesis
por: Ala, Yaswanth, et al.
Publicado: (2015)

Effect of pregnancy on serum cytokines in SLE patients
por: Doria, Andrea, et al.
Publicado: (2012)

Performance of cytokine models in predicting SLE activity
por: Ruchakorn, Nopparat, et al.
Publicado: (2019)

Chitosan IFN-γ-pDNA Nanoparticle (CIN) Therapy for Allergic Asthma
por: Kumar, Mukesh, et al.
Publicado: (2003)

A novel fully human monoclonal antibody that neutralizes multiple human IFN-α subtypes effectively: a candidate therapy for SLE
por: Wang, Shuang, et al.
Publicado: (2015)

Clinical impact of biologic therapy in the treatment of SLE
por: Wallace, Daniel J
Publicado: (2013)

Patient perceptions and preferences of biologic therapies in SLE
por: Lim, S Sam, et al.
Publicado: (2019)

Cytokine-Modulating Strategies and Newer Cytokine Targets for Arthritis Therapy
por: Venkatesha, Shivaprasad H., et al.
Publicado: (2014)

IFN-γ, IL-17 and TGF-β involvement in shaping the tumor microenvironment: The significance of modulating such cytokines in treating malignant solid tumors
por: Alshaker, Heba A, et al.
Publicado: (2011)

Roles of Pro- and Anti-Inflammatory Cytokines in the Pathogenesis of SLE
por: Su, Ding-Lei, et al.
Publicado: (2012)

Increased Expression of PPAR-γ Modulates Monocytes Into a M2-Like Phenotype in SLE Patients: An Implicative Protective Mechanism and Potential Therapeutic Strategy of Systemic Lupus Erythematosus
por: Liu, Yu, et al.
Publicado: (2021)

Intravenous Cyclophosphamide Therapy for Anti-IFN-γ Autoantibody-Associated Talaromyces marneffei Infection
por: Zeng, Wen, et al.
Publicado: (2022)

Targeted Therapy for SLE—What Works, What Doesn’t, What’s Next
por: Venturelli, Veronica, et al.
Publicado: (2023)

Risk factors of significant relapse and appropriate maintenance therapy strategy in SLE-associated immune thrombocytopenia
por: Li, He-Jun, et al.
Publicado: (2023)

Th2 Cytokine Levels Distort the Association of IL-10 and IFN-γ with Allergic Phenotypes
por: Zhang, Guicheng, et al.
Publicado: (2011)

Induction of IFN-γ cytokine response against hepatitis B surface antigen using melittin
por: Dezfuli, Hoda Taghizadeh, et al.
Publicado: (2014)

Inflamm-Aging-Related Cytokines of IL-17 and IFN-γ Accelerate Osteoclastogenesis and Periodontal Destruction
por: Tan, Jingyi, et al.
Publicado: (2021)

Expressions of IL4, IL10, and IFNγ cytokines genes during bacterial mastitis
por: Faaz, Rana A., et al.
Publicado: (2022)

Blockade Effects of Anti-Interferon- (IFN-) γ Autoantibodies on IFN-γ-Regulated Antimicrobial Immunity
por: Krisnawati, Dyah Ika, et al.
Publicado: (2019)

Elevated serum IFN-γand IFN-γ/IL-6 ratio in Kikuchi-Fujimoto disease
por: He, Tingyan, et al.
Publicado: (2023)

PReS13-SPK-1129: Biologic therapies in SLE
por: Isenberg, DA
Publicado: (2013)

Systemic Lupus Erythematosus (SLE) Therapy: The Old and the New
por: Basta, Fabio, et al.
Publicado: (2020)

Innate IFN-γ-Producing Cells in the Spleen of Mice Early after Listeria monocytogenes Infection: Importance of Microenvironment of the Cells Involved in the Production of Innate IFN-γ
por: Kubota, Koichi, et al.
Publicado: (2011)

IFNα and IFNγ Impede Marek’s Disease Progression
por: Bertzbach, Luca D., et al.
Publicado: (2019)

SLE: Novel Postulates for Therapeutic Options
por: Hosszu, Kinga K., et al.
Publicado: (2020)

Conventional DCs from Male and Female Lupus-Prone B6.NZM Sle1/Sle2/Sle3 Mice Express an IFN Signature and Have a Higher Immunometabolism That Are Enhanced by Estrogen
por: Lee, Michael H., et al.
Publicado: (2018)

Cytokine Profiling in Chinese SLE Patients: Correlations with Renal Dysfunction
por: Yan, Chen, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_157bk7e4fqaj26opudb7ufsj6m